The Epstein-Barr virus (EBV) latent membrane protein (LMP1) is expressed in most of the malignancies associated with EBV and its expression in lymphoid and epithelial cell lines profoundly affects their biologic phenotype and gene expression. LMP1 is the only EBV gene that can transform immortalized rodent fibroblast lines to loss of contact inhibition, lower serum dependence, anchorage independence, and tumorigenicity in nude mice. LMP1 interacts with the tumor necrosis factor receptor (TNFR) associated factors (TRAFS) through which it activates the NFkB transcription factor and JNK kinase. We have generated three lineages of LMP 1 transgenic mice with LMP l expressed under the control of the heavy chain immunoglobulin promoter/enhancer. The mice have a 5 fold increase in the development of B cell lymphoma with LMP1 expressed at high levels in the lymphoma tissues. This result indicates that LMP1, without expression of other EBV genes, is oncogenic in vivo and suggests that LMP1 is a major contributing factor to the development of EBV-associated lymphomas. We have also shown that LMP1 induces the expression of epidermal growth factor receptor (EGFR) through the TRAF interacting domain and by mutating the TRAF interacting have produced two temperature sensitive mutants with regard to EGFR induction. Our preliminary data indicates that LMP1 also induces expression of the EGFR in rodent fibroblasts. In this grant, we will determine the biochemical basis of LMP1-mediated transformation and identify cellular genes that contribute to oncogenesis.
Our specific aims are to l) further characterize the transgenic lymphomas by identifying the molecular interactions of LMP1 and the activated signaling pathways, 2) determine if LMP1 expression in transgenic mice synergizes with activation of the nuclear oncogene, c-myc, 3) determine if inactivation of the tumor suppressor, p53, increases the malignant potential of LMP1 in transgenic mice, 4) characterize LMP l transformation of rodent fibroblasts by identifying the essential domains of LMP1 and the signaling pathways that are activated, 5) determine the contribution of EGFR induction by LMP1 to rodent fibroblast transformation using inhibitors of EGFR signaling and two temperature sensitive forms of LMP1.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
2P01CA019014-22A1
Application #
6203028
Study Section
Project Start
1999-09-30
Project End
2000-07-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
22
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
DeKroon, Robert M; Gunawardena, Harsha P; Edwards, Rachel et al. (2018) Global Proteomic Changes Induced by the Epstein-Barr Virus Oncoproteins Latent Membrane Protein 1 and 2A. MBio 9:
Nicholls, Thomas J; Nadalutti, Cristina A; Motori, Elisa et al. (2018) Topoisomerase 3? Is Required for Decatenation and Segregation of Human mtDNA. Mol Cell 69:9-23.e6
El-Mallawany, Nader Kim; Kamiyango, William; Villiera, Jimmy et al. (2018) Proposal of a Risk-Stratification Platform to Address Distinct Clinical Features of Pediatric Kaposi Sarcoma in Lilongwe, Malawi. J Glob Oncol :1-7
Selitsky, Sara R; Marron, David; Mose, Lisle E et al. (2018) Epstein-Barr Virus-Positive Cancers Show Altered B-Cell Clonality. mSystems 3:
Hosseinipour, Mina C; Kang, Minhee; Krown, Susan E et al. (2018) As-Needed Vs Immediate Etoposide Chemotherapy in Combination With Antiretroviral Therapy for Mild-to-Moderate AIDS-Associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial. Clin Infect Dis 67:251-260
Lyons, Danielle E; Yu, Kuan-Ping; Vander Heiden, Jason A et al. (2018) Mutant Cellular AP-1 Proteins Promote Expression of a Subset of Epstein-Barr Virus Late Genes in the Absence of Lytic Viral DNA Replication. J Virol 92:
Bigi, Rachele; Landis, Justin T; An, Hyowon et al. (2018) Epstein-Barr virus enhances genome maintenance of Kaposi sarcoma-associated herpesvirus. Proc Natl Acad Sci U S A 115:E11379-E11387
El-Mallawany, Nader Kim; Villiera, Jimmy; Kamiyango, William et al. (2018) Endemic Kaposi sarcoma in HIV-negative children and adolescents: an evaluation of overlapping and distinct clinical features in comparison with HIV-related disease. Infect Agent Cancer 13:33
Kobayashi, E; Aga, M; Kondo, S et al. (2018) C-Terminal Farnesylation of UCH-L1 Plays a Role in Transport of Epstein-Barr Virus Primary Oncoprotein LMP1 to Exosomes. mSphere 3:
Hopcraft, Sharon E; Pattenden, Samantha G; James, Lindsey I et al. (2018) Chromatin remodeling controls Kaposi's sarcoma-associated herpesvirus reactivation from latency. PLoS Pathog 14:e1007267

Showing the most recent 10 out of 324 publications